UNIVERSAL IBOGAINE INC.

Research UNIVERSAL IBOGAINE INC. (JC4) on Bullrun: market cap EUR 1.10M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerJC4
ExchangeF
CountryCanada
SectorHealthcare
IndustryBiotechnology
CurrencyEUR
Market capEUR 1.10M
Financial periodQ2 2025
RevenueCAD 700.92K
Net income-CAD 66.20K
Free cash flow-CAD 110.37K

Valuation Snapshot

latest market cap is EUR 1.10M.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-14	EUR 1.10M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About UNIVERSAL IBOGAINE INC.

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada.

Related stock research

Canada stocks Canada Healthcare stocks A-Z stock index

Other Healthcare stocks

Entheon Biomedical Corp. (1XU) NANOSPHERE HEA.SCIENCES (2CG) MedMira Inc (47M) BRAXIA SCIENTIFIC CORP. (4960) WAVERLEY PHARMA INC. (5GZ) BioVaxys Technology Corp. (5LB0) GLOW LIFETECH CORP. (9DO) NERVGEN PHARMA CORP. (9UA) AbCellera Biologics Inc (ABCL) Appili Therapeutics Inc (APLI) Arch Biopartners Inc (ARCH) Aurinia Pharmaceuticals Inc (AUPH)

Frequently asked questions

What is UNIVERSAL IBOGAINE INC.'s market cap?

UNIVERSAL IBOGAINE INC.'s market capitalization is EUR 1.10M.